ZIRABEV 25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1211004740010 -
GGREM
522722050090607 -
Barcode
7891045033183
What the source publishes
- Holder
- PFIZER BRASIL LTDA
- Active ingredients
- BEVACIZUMABE
- Package
- 25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML
- Product type
- Biológico
- Therapeutic class
- L1G2 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, VEGF/VEGFR
Names this record is found by
Complete source data
{
"name": "ZIRABEV 25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML",
"holder": "PFIZER BRASIL LTDA",
"stripe": null,
"barcodes": [
"7891045033183"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "522722050090607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "61.072.393/0001-33",
"priceRegime": "Regulado",
"productName": "ZIRABEV",
"productType": "Biológico",
"hospitalOnly": true,
"presentation": "25 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 4 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "1204.24",
"icms-12": "1368.45",
"icms-17": "1450.89",
"icms-18": "1468.59",
"icms-19": "1486.72",
"icms-20": "1505.30",
"icms-21": "1524.35",
"icms-22": "1543.90",
"icms-23": "1563.95",
"icms-17.5": "1459.68",
"icms-19.5": "1495.95",
"icms-20.5": "1514.77",
"icms-22.5": "1553.86",
"icms-12-alc": "1352.03",
"icms-17-alc": "1433.48",
"icms-18-alc": "1450.96",
"icms-19-alc": "1468.88",
"icms-20-alc": "1487.24",
"icms-21-alc": "1506.06",
"icms-22-alc": "1525.37",
"icms-23-alc": "1545.18",
"withoutTaxes": "1189.79",
"icms-17.5-alc": "1442.17",
"icms-19.5-alc": "1478.00",
"icms-20.5-alc": "1496.59",
"icms-22.5-alc": "1535.21"
},
"pisCofinsList": "Positiva",
"substanceText": "BEVACIZUMABE",
"targetSpecies": [],
"consumerPrices": null,
"invalidBarcodes": [],
"activeSubstances": [
"BEVACIZUMABE"
],
"therapeuticClass": "L1G2 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, VEGF/VEGFR",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1211004740010",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "L1G2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:522722050090607"